Apotea
Research Apotea (APOTEA) on Bullrun: valuation model: 8.7% overvalued, market cap SEK 7.72B, P/E 31.4, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAPOTEA
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencySEK
- Valuation signal8.7% overvalued
- Market capSEK 7.72B
- P/E31.4
- Dividend yield0.8%
- Financial periodQ2 2026
- RevenueSEK 2.03B
- Net incomeSEK 81.40M
- Free cash flowSEK 73.90M
- Gross margin27.5%
Valuation Snapshot
Bullrun's latest valuation model marks Apotea as 8.7% overvalued; latest market cap is SEK 7.72B; P/E is 31.4; dividend yield is 0.8%.
Peer valuation comparison
Latest P/E is 31.42x versus a Healthcare sector median of 24.46x (28.5% above).
Latest dividend yield is 0.79% versus a Healthcare sector median of 2.11% (62.6% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 7.21B | SEK 228.70M | n/a | 19.5% | n/a | SEK 30.60M | SEK 331.00M | SEK 844.00M |
| FY2024 | SEK 6.54B | SEK 212.00M | SEK 43.40M | 27.3% | 2.09 | SEK 27.30M | SEK 79.60M | SEK 615.20M |
| FY2023 | SEK 5.45B | SEK 82.40M | SEK 95.90M | 26.6% | 0.85 | SEK 19.10M | SEK 66.90M | SEK 403.70M |
| FY2022 | SEK 4.88B | SEK 19.90M | n/a | 16.4% | n/a | SEK 18.20M | n/a | SEK 355.10M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 7.72B | 31.4 | 0.8% | 0.6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.6 SEK, yield 0.8%.
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Apotea overvalued or undervalued?
Bullrun's valuation model currently marks Apotea as 8.7% overvalued.
What is Apotea's market cap?
Apotea's market capitalization is SEK 7.72B.
What is Apotea's P/E ratio?
Apotea's price-to-earnings (P/E) ratio is 31.4.
Does Apotea pay a dividend?
Apotea has a dividend yield of 0.8%.
What does Apotea do?
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements.